Synopsys, Inc. $SNPS Shares Acquired by Candriam S.C.A.

Candriam S.C.A. boosted its stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 4.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 93,639 shares of the semiconductor company’s stock after acquiring an additional 4,221 shares during the period. Candriam S.C.A. owned 0.05% of Synopsys worth $46,201,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Alpine Bank Wealth Management lifted its holdings in shares of Synopsys by 89.3% during the third quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares during the period. TFC Financial Management Inc. increased its stake in Synopsys by 1,250.0% in the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock valued at $27,000 after buying an additional 50 shares during the period. Millstone Evans Group LLC purchased a new position in Synopsys during the 3rd quarter worth $27,000. SOA Wealth Advisors LLC. acquired a new stake in shares of Synopsys in the 3rd quarter worth $28,000. Finally, McIlrath & Eck LLC purchased a new stake in shares of Synopsys in the third quarter valued at about $29,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

SNPS has been the subject of a number of recent analyst reports. KeyCorp raised their price objective on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Wells Fargo & Company lifted their price target on Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research note on Thursday, December 11th. Rosenblatt Securities upgraded Synopsys from a “neutral” rating to a “buy” rating and cut their price objective for the stock from $605.00 to $560.00 in a research report on Tuesday, December 9th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $553.57.

Get Our Latest Stock Analysis on SNPS

Insider Buying and Selling

In other Synopsys news, insider Janet Lee sold 250 shares of the stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider owned 11,959 shares in the company, valued at approximately $6,338,270. This represents a 2.05% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $460.77, for a total value of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. This trade represents a 17.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 4,157 shares of company stock worth $1,945,036. 0.62% of the stock is owned by corporate insiders.

Synopsys Trading Up 4.0%

Shares of SNPS stock opened at $426.88 on Monday. The stock has a market cap of $81.67 billion, a P/E ratio of 53.43, a P/E/G ratio of 3.56 and a beta of 1.12. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The business has a fifty day simple moving average of $479.33 and a 200-day simple moving average of $495.06.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The firm’s revenue was up 37.8% on a year-over-year basis. During the same period in the prior year, the company earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.